Christopher C. Benz
Affiliations: | University of California, Berkeley, Berkeley, CA, United States |
Area:
Biomedical EngineeringGoogle:
"Christopher Benz"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Heckenbach I, Peila R, Benz C, et al. (2025) Cellular senescence predicts breast cancer risk from benign breast disease biopsy images. Breast Cancer Research : Bcr. 27: 37 |
| Heckenbach I, Powell M, Fuller S, et al. (2024) Deep learning assessment of senescence-associated nuclear morphologies in mammary tissue from healthy female donors to predict future risk of breast cancer: a retrospective cohort study. The Lancet. Digital Health. 6: e681-e690 |
| Sundaram L, Kumar A, Zatzman M, et al. (2024) Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers. Science (New York, N.Y.). 385: eadk9217 |
| George MF, Paff S, Rojo J, et al. (2024) Assessment of salivary cadmium levels and breast density in the Marin Women's Study. Cancer Medicine. 13: e6973 |
| Clelland EN, Rothschild HT, Patterson A, et al. (2023) Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes. Breast Cancer Research and Treatment |
| Heckenbach I, Powell M, Fuller S, et al. (2023) Breast cancer risk based on a deep learning predictor of senescent cells in normal tissue. Medrxiv : the Preprint Server For Health Sciences |
| Powell M, Fuller S, Gunderson E, et al. (2022) A common IGF1R gene variant predicts later life breast cancer risk in women with preeclampsia. Breast Cancer Research and Treatment |
| Johansson A, Dar H, van 't Veer LJ, et al. (2022) Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2102844 |
| Johansson A, Yu NY, Iftimi A, et al. (2022) Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature. International Journal of Cancer |
| Rothschild HT, Abel MK, Patterson A, et al. (2021) Obesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancer. Breast Cancer Research and Treatment. 191: 451-458 |